Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy

Matvey Lukashev, Doreen LePage, Cheryl Wilson, Veronique Bailly, Ellen Garber, Alex Lukashin, Apinya Ngam-ek, Weike Zeng, Norman Allaire, Steve Perrin, Xianghong Xu, Kendall Szeliga, Kathleen Wortham, Rebecca Kelly, Cindy Bottiglio, Jane Ding, Linda Griffith, Glenna Heaney, Erika Silverio, William YangMatt Jarpe, Stephen Fawell, Mitchell Reff, Amie Carmillo, Konrad Miatkowski, Joseph Amatucci, Thomas Crowell, Holly Prentice, Werner Meier, Shelia M Violette, Fabienne Mackay-Fisson, Dajun Yang, Robert Hoffman, Jeffrey L Browning

Research output: Contribution to journalArticleResearchpeer-review

72 Citations (Scopus)
Original languageEnglish
Pages (from-to)9617 - 9624
Number of pages8
JournalCancer Research
Volume66
Issue number19
DOIs
Publication statusPublished - 2006
Externally publishedYes

Cite this

Lukashev, M., LePage, D., Wilson, C., Bailly, V., Garber, E., Lukashin, A., Ngam-ek, A., Zeng, W., Allaire, N., Perrin, S., Xu, X., Szeliga, K., Wortham, K., Kelly, R., Bottiglio, C., Ding, J., Griffith, L., Heaney, G., Silverio, E., ... Browning, J. L. (2006). Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Research, 66(19), 9617 - 9624. https://doi.org/10.1158/0008-5472.CAN-06-0217